Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Sep 14, 2022 10:29am
RE:RE:RE:ENDO
It is a shame - but - I recall when Goodman pointed out what a mess Endo was in. His comments were also related generally to the "drunken sailor" approach to buying pharma assets using
...more
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Sep 13, 2022 10:33pm
RE:RE:ENDO
Nasdaq also announced today that it will delist the ordinary shares of Endo International plc. Endo International plc’s shares were suspended on August 26, 2022 and have not traded on Nasdaq since
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(7)
•••
cynthieess
X
View Profile
View Bullboard History
Post by
cynthieess
on Sep 12, 2022 8:09pm
On watch
Technical indicator Stochastic oscillator and RSI go green. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Sep 12, 2022 8:01pm
Cancer Moonshot initiative
Cancer moonshot initiative- Biden speaking today about beating cancer we can do this together Cancer ‘Moonshot’ initiative Aim to cut cancer deaths by half over next 25
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Sep 12, 2022 6:08pm
RE:CNBC guest talking up pharma and biotech
Losers...losers....losers. When will your illusion end
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Sep 12, 2022 4:00pm
CNBC guest talking up pharma and biotech
How cancer will be beaten, other diseases and therapies will be huge discoveries by smaller biotech pharma co, partnerships/ buyouts by bigger companies
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Sep 11, 2022 10:04am
RE:RE:RE:Only 200 shares traded @ 10:15
I missed that - was on a train going to the Antibe AGM. Just love the potential at ATE for GUD shareholders - got my fingers crossed for a future of opportunity there. Wouldn't surprise me
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Comment by
GoldenInvestor
on Sep 10, 2022 4:30pm
RE:RE:Only 200 shares traded @ 10:15
Thanks! I figured it wasn't but was curious why nothing had traded , just 200 shares u til >+45 mins in. it seemed stranger then picked up thereafter
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Sep 10, 2022 2:25pm
RE:Only 200 shares traded @ 10:15
Actually Golden ... if you look at the top of this Stockhouse siite - to the right of the GUD share price, you will see the bid/ask identified. If one of those is replaced by a red circle with a
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Sep 09, 2022 10:16am
Only 200 shares traded @ 10:15
Is there a halt? News pending? just curious.
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Sep 08, 2022 3:09pm
RE:buybacks
Interesting! 5.7962 was the highest price they paid (for 100,000 shares).
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Sep 08, 2022 11:50am
Population to double or greater in 8 years needing Exelon
in Brazil alone! In recent post states the rapidly growing need for products just reintroduced in Brazil! Add to that all the other South American Countries that will be able to benefit from Exelon
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Sep 08, 2022 8:24am
RE:buybacks
The dream ...the inpossible dream .............ho....paladinho....paladin Mug/Gold lost a fortunes waitng for you
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Sep 07, 2022 4:31pm
buybacks
Filed 2022-09-07 15:21 Tx date 2022-08-31 $GUD Knight Therapeutics Inc. Knight Therapeutics Inc. 1 - Issuer Direct Ownership
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023